60
Participants
Start Date
July 1, 2024
Primary Completion Date
June 1, 2026
Study Completion Date
December 31, 2026
Difluprednate Ophthalmic
Difluprednate 0.05% is a corticosteroid used to reduce inflammation in the eye. Participants will receive one drop of 0.05% difluprednate four times daily beginning 24 hours after the initiation of antibiotics for 1 week, decreased by 1 drop weekly for a total of 4 weeks of steroid therapy.
Rose Bengal
Study participants receive RB-PDT within 48 hours of randomization. All participants will receive a 30-minute loading dose of topical Rose Bengal (0.1% RB in 0.9% sodium chloride) which will be applied in 3-minute intervals to the de-epithelialized cornea. This will be followed by irradiation with a 6mW/cm2 custom-made green LED source for 15 minutes (5.4J/cm2). Repeat cornea culture will be collected within 24 hours after the procedure.
Moxifloxacin Ophthalmic
Topical moxifloxacin 0.5% is a fluoroquinolone antibiotic that is used to treat bacterial infections. This is a standard therapy for bacterial keratitis.
RECRUITING
Federal University of São Paulo, São Paulo
RECRUITING
Aravind Eye Care System, Madurai
Stanford University
OTHER
Aravind Eye Care System
OTHER
Federal University of São Paulo
OTHER
University of California, San Francisco
OTHER